Examining the Link Between Depression and Seasonal Allergies

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-07-15

Study Completion Date

2017-04-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will examine whether spring and fall seasonal depression in individuals with high sensitivity to pollen is linked to seasonal increases in tree and ragweed pollen.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Associations Between Depression and Cardiovascular Disease - a Study of Patients With Late Onset Depression

NCT00818506

Depression Major Depressive Disorder Cardiovascular Disease +1 more

COMPLETED

Coronary Heart Disease Incidence: Depression & Inflammation Risk

NCT00241774

Cardiovascular Diseases Coronary Disease Heart Diseases +2 more

COMPLETED

Influenza Vaccine as a Novel Experimental Model of the Behavioral Immune Response in Depression

NCT03756246

Depression Healthy

UNKNOWN PHASE4

Predicting Effectiveness of Light Treatment for Winter Seasonal Affective Disorder

NCT00742365

Depression

COMPLETED

Long-term Observation of Participants With Mood Disorders

NCT04877977

Depression Suicide Risk

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Those who suffer from depression have their normal lives interrupted by symptoms such as persistent sad thoughts, inability to feel pleasure, and potential suicide. Suicide and depression peak in the spring and fall. Worsening of depression, admission to a hospital for depression and bipolar depression, and use of electroconvulsive therapy for treatment of depression all peak in the spring. Although seasonal affective disorder (SAD), in which depression corresponds with seasonal changes, is commonly associated with the winter subtype, SAD is actually more prevalent as the spring subtype.

Allergies, which also peak in the spring and fall, have been linked to depression. Allergic reactions release cytokines, which are proteins that mediate the immune system response when a foreign substance enters the body. Previous studies have found both that an increase in cytokines in otherwise healthy individuals causes depressive symptoms and that cytokines cause the chemical tryptophan (TRP) to switch from producing serotonin, a neurotransmitter associated with feelings of well-being, to producing kynurenine (KYN), a potentially toxic chemical. To determine whether and to what extent allergies are linked to depression, this study will compare depression levels of participants with and without allergies before and during peak times for seasonal allergies. Results from this study may be used in further research to examine the effects of allergy prevention on depression.

Participants in this study will meet with researchers three times. At the first visit, they will be screened for allergies and give their demographic information. The timing of the second and third visits will depend on each participant's allergies. Those with spring allergies will be tested before and then during the spring allergy season. Those with fall allergies or with no allergies will be tested before and then during the fall allergy season. On the second and third visits questionnaires and clinical interviews will assess depression symptoms, and blood tests will be performed to measure chemical levels of cytokines, TRP, and KYN. During these visits participants will also be asked to complete a sleep log for 1 week. This will entail describing their sleep, activity, caffeine consumption, alcohol consumption, and use of sleep medications. A subgroup will wear an Actiwatch device, which electronically monitors sleep and wakefulness cycles, for 1 week, 24 hours a day.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

All participants testing positive for tree and ragweed pollen allergies, as determined by levels of immunoglobulin E (IgE) antibodies

No interventions assigned to this group

Control group

All participants testing negative for tree and ragweed pollen allergies, as determined by levels of IgE antibodies

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of major depressive disorder or bipolar disorder

Exclusion Criteria

* Pregnancy or intention to become pregnant within the duration of the study
* Dependence on alcohol, cocaine, stimulants, benzodiazepines, marijuana, or opiates
* Major medical illness, including cancer, hepatitis, and autoimmune disease
* A winter subtype of seasonal affective disorder
* Diagnosis of psychotic disorder
* Positive result in Phadiatop allergy test, but negative result in tree or ragweed pollen IgE test

Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No